AR013742A1 - Metodo para el tratamiento de la hipercolesterolemia con polidialilamina no substituida - Google Patents
Metodo para el tratamiento de la hipercolesterolemia con polidialilamina no substituidaInfo
- Publication number
- AR013742A1 AR013742A1 ARP980105512A ARP980105512A AR013742A1 AR 013742 A1 AR013742 A1 AR 013742A1 AR P980105512 A ARP980105512 A AR P980105512A AR P980105512 A ARP980105512 A AR P980105512A AR 013742 A1 AR013742 A1 AR 013742A1
- Authority
- AR
- Argentina
- Prior art keywords
- polidialilamine
- hypercholesterolemia
- substituted
- treatment
- patient
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Abstract
Un método para eliminar sales bibliares de un paciente, que incluye la administracion al paciente de una cantidad terapéuticamente efectiva depolímeros de polidialilamina no absorbibles de formulas (I) y (II).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/964,536 US6083497A (en) | 1997-11-05 | 1997-11-05 | Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers |
Publications (1)
Publication Number | Publication Date |
---|---|
AR013742A1 true AR013742A1 (es) | 2001-01-10 |
Family
ID=25508662
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980105512A AR013742A1 (es) | 1997-11-05 | 1998-03-11 | Metodo para el tratamiento de la hipercolesterolemia con polidialilamina no substituida |
Country Status (20)
Country | Link |
---|---|
US (6) | US6083497A (es) |
EP (1) | EP1028717B1 (es) |
JP (1) | JP4649039B2 (es) |
KR (1) | KR20010031822A (es) |
CN (1) | CN1278180A (es) |
AR (1) | AR013742A1 (es) |
AT (1) | ATE235236T1 (es) |
AU (1) | AU746876B2 (es) |
BR (1) | BR9813961A (es) |
CA (1) | CA2309027C (es) |
DE (1) | DE69812681T2 (es) |
ES (1) | ES2196625T3 (es) |
HU (1) | HUP0004279A3 (es) |
IL (1) | IL135858A0 (es) |
NO (1) | NO20002172L (es) |
NZ (1) | NZ504216A (es) |
PL (1) | PL340296A1 (es) |
TW (1) | TW453878B (es) |
WO (1) | WO1999022721A2 (es) |
ZA (1) | ZA989673B (es) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5667775A (en) * | 1993-08-11 | 1997-09-16 | Geltex Pharmaceuticals, Inc. | Phosphate-binding polymers for oral administration |
US6268392B1 (en) * | 1994-09-13 | 2001-07-31 | G. D. Searle & Co. | Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors |
US6083497A (en) * | 1997-11-05 | 2000-07-04 | Geltex Pharmaceuticals, Inc. | Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers |
US6221897B1 (en) * | 1998-06-10 | 2001-04-24 | Aventis Pharma Deutschland Gmbh | Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use |
US6733780B1 (en) | 1999-10-19 | 2004-05-11 | Genzyme Corporation | Direct compression polymer tablet core |
IL149146A0 (en) * | 1999-10-19 | 2002-11-10 | Geltex Pharma Inc | Direct compression polymer tablet core |
GB9927088D0 (en) * | 1999-11-17 | 2000-01-12 | Secr Defence | Use of poly(diallylamine) polymers |
FI113613B (fi) * | 1999-11-24 | 2004-05-31 | Eritocap Oy | Elintarvikekoostumukset ja menetelmiä niiden valmistamiseksi |
NZ528829A (en) * | 2001-04-18 | 2006-06-30 | Genzyme Corp | Low salt forms of polyallylamine |
EP1923064B1 (en) | 2001-04-18 | 2017-06-28 | Genzyme Corporation | Use of amine polymer for lowering serum glucose |
WO2002085379A1 (en) * | 2001-04-18 | 2002-10-31 | Geltex Pharmaceuticals, Inc. | Method for improving vascular access in patients with vascular shunts |
AU2002257147B9 (en) * | 2001-04-18 | 2005-08-18 | Genzyme Corporation | Methods of treating syndrome X with aliphatic polyamines |
WO2002085380A1 (en) * | 2001-04-18 | 2002-10-31 | Geltex Pharmaceuticals, Inc. | Method for treating gout and reducing serum uric acid |
AU2002257145B2 (en) * | 2001-04-18 | 2005-06-02 | Genzyme Corporation | Method for lowering serum glucose |
US7041280B2 (en) * | 2001-06-29 | 2006-05-09 | Genzyme Corporation | Aryl boronate functionalized polymers for treating obesity |
CA2456732C (en) | 2001-08-07 | 2012-10-30 | Galephar M/F | Oral pharmaceutical composition containing a combination of ppar.alpha. and a hmg-coa reductase inhibitor |
US7223887B2 (en) * | 2001-12-18 | 2007-05-29 | The University Of British Columbia | Multivalent cationic lipids and methods of using same in the production of lipid particles |
TW200404544A (en) * | 2002-06-17 | 2004-04-01 | Kowa Co | Controlled release pharmaceutical composition |
US20050101565A1 (en) * | 2002-07-03 | 2005-05-12 | Esperion Therapeutics, Inc. | Pharmaceutical compositions and methods for treating, preventing, and managing cholesterol, dyslipidemia, and related disorders |
US6565896B1 (en) * | 2002-07-03 | 2003-05-20 | Vitacost.Com, Inc. | Cholesterol treatment formulation |
AT411463B (de) | 2002-09-03 | 2004-01-26 | Dsm Fine Chem Austria Gmbh | Verfahren zur herstellung von alkylierten n- bzw. amino-, ammonium- oder spirobicyclischen ammoniumgruppen haltigen, vernetzten polymeren |
WO2004037274A1 (en) * | 2002-10-22 | 2004-05-06 | Genzyme Corporation | Amine polymers for promoting bone formation |
AT412473B (de) | 2003-01-15 | 2005-03-25 | Dsm Fine Chem Austria Gmbh | Verfahren zur kontinuierlichen trocknung von n- bzw. amino-, ammonium- oder spirobicyclische ammoniumgruppen haltigen polymeren |
US7264813B2 (en) * | 2003-09-24 | 2007-09-04 | Nikken Sohonsha Corporation | Therapeutic uses of Dunaliella powder |
US20050106267A1 (en) | 2003-10-20 | 2005-05-19 | Framework Therapeutics, Llc | Zeolite molecular sieves for the removal of toxins |
US7022713B2 (en) * | 2004-02-19 | 2006-04-04 | Kowa Co., Ltd. | Hyperlipemia therapeutic agent |
US20050244367A1 (en) * | 2004-05-03 | 2005-11-03 | Ilypsa, Inc. | Phospholipase inhibitors localized in the gastrointestinal lumen |
US7985418B2 (en) | 2004-11-01 | 2011-07-26 | Genzyme Corporation | Aliphatic amine polymer salts for tableting |
JP2008533272A (ja) * | 2005-03-16 | 2008-08-21 | ユーエスヴィー リミテッド | 架橋ポリアリルアミンポリマーの調製のための改良された方法 |
US20070014866A1 (en) * | 2005-07-15 | 2007-01-18 | Curt Hendrix | Composition for improving the efficacy and reducing the side effects of omega 3 fatty acids, fish oils and cardiovascular and diabetic treatments |
US8986669B2 (en) * | 2005-09-02 | 2015-03-24 | Genzyme Corporation | Method for removing phosphate and polymer used therefore |
AR056499A1 (es) * | 2005-09-06 | 2007-10-10 | Serapis Farmaceuticals Ltd | Compuestos |
EP1924618A1 (en) * | 2005-09-12 | 2008-05-28 | Council of Scientific and Industrial Research | Bile acid sequestrant and process for preparation thereof |
AU2012205214B2 (en) * | 2005-09-15 | 2015-05-21 | Genzyme Corporation | Formulation for Amine Polymers |
CN103027896B (zh) * | 2005-09-15 | 2016-01-20 | 基酶有限公司 | 胺聚合物的小袋制剂 |
EP2016114A2 (en) * | 2006-05-05 | 2009-01-21 | Genzyme Corporation | Amine condensation polymers as phosphate sequestrants |
BRPI0715053A2 (pt) * | 2006-07-18 | 2013-03-19 | Genzyme Corp | composiÇço farmacÊutica, mÉtodo para tratar doenÇas, e, polÍmero |
WO2008042222A2 (en) | 2006-09-29 | 2008-04-10 | Genzyme Corporation | Amide dendrimer compositions |
US20080118572A1 (en) * | 2006-10-10 | 2008-05-22 | Harold Richard Hellstrom | Methods and compositions for reducing the risk of adverse cardiovascular events associated with the administration of artificial blood |
US8163799B2 (en) * | 2006-12-14 | 2012-04-24 | Genzyme Corporation | Amido-amine polymer compositions |
JP2010519298A (ja) * | 2007-02-23 | 2010-06-03 | ゲンズイメ コーポレーション | アミンポリマー組成物 |
JP2010520208A (ja) * | 2007-03-01 | 2010-06-10 | コンコース ヘルス サイエンシーズ エルエルシー | イノシトールナイアシネートの異性体及びその使用 |
EP2131820A1 (en) * | 2007-03-08 | 2009-12-16 | Genzyme Corporation | Sulfone polymer compositions |
EP2152277A1 (en) * | 2007-04-27 | 2010-02-17 | Genzyme Corporation | Amido-amine dendrimer compositions |
EP2217215A1 (en) * | 2007-12-14 | 2010-08-18 | Genzyme Corporation | Coated pharmaceutical compositions |
US20110142952A1 (en) * | 2008-06-20 | 2011-06-16 | Harris David J | Pharmaceutical Compositions |
WO2010014541A2 (en) * | 2008-07-28 | 2010-02-04 | Alnara Pharmaceuticals, Inc. | Compositions and methods for treatment of hypercholesterolemia |
DE102009040089A1 (de) * | 2009-09-04 | 2011-07-21 | Beiersdorf AG, 20253 | Zubereitungen mit wasserunlöslichen polymeren Aminen zur Verminderung von Körpergeruch |
AU2011220748B2 (en) * | 2010-02-24 | 2015-11-05 | Relypsa, Inc. | Amine polymers for use as bile acid sequestrants |
US20130156720A1 (en) | 2010-08-27 | 2013-06-20 | Ironwood Pharmaceuticals, Inc. | Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders |
CN102993348B (zh) * | 2011-09-09 | 2014-11-12 | 北大方正集团有限公司 | 一种烟酸司维拉姆及其制备方法和用途 |
CN103012789B (zh) * | 2011-09-23 | 2015-02-25 | 北大方正集团有限公司 | 烟酸司维拉姆的制备方法 |
JP6217938B2 (ja) | 2011-10-28 | 2017-10-25 | ルメナ ファーマシューティカルズ エルエルシー | 小児の胆汁うっ滞性肝疾患の処置のための胆汁酸再循環阻害剤 |
CN103030713A (zh) * | 2012-12-21 | 2013-04-10 | 江南大学 | 一种具有降血脂活性的低分子量葡聚糖-烟酸聚合物的制备方法 |
MA41202A (fr) | 2014-12-18 | 2017-10-24 | Genzyme Corp | Copolymères polydiallymine réticulé pour le traitement du diabète de type 2 |
US10245284B2 (en) | 2015-08-19 | 2019-04-02 | Alpex Pharma S.A. | Granular composition for oral administration |
WO2024040380A1 (zh) * | 2022-08-22 | 2024-02-29 | 中美华世通生物医药科技(武汉)股份有限公司 | 铵盐聚合物及其制备方法和作为胆汁酸螯合剂的用途 |
Family Cites Families (89)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR593106A (fr) | 1924-02-15 | 1925-08-17 | Rhenania Ver Chemischer Fab Ag | Procédé de production de chlore très concentré |
US2926161A (en) * | 1958-03-10 | 1960-02-23 | Peninsular Chem Res Inc | Linear homopolymers of diallyl amines |
GB860303A (en) | 1958-06-20 | 1961-02-01 | Ici Ltd | Pharmaceutical compositions comprising ª‡-aryloxy-aliphatic carboxylic acids and/or ª |
US3288770A (en) * | 1962-12-14 | 1966-11-29 | Peninsular Chem Res Inc | Water soluble quaternary ammonium polymers |
SE337383B (es) | 1965-01-05 | 1971-08-09 | Yoshitomi Pharmaceutical | |
FR1498459A (es) | 1965-07-30 | 1968-01-08 | ||
GB1175516A (en) | 1966-04-15 | 1969-12-23 | Science Union & Cie | New Phenyl-Aminopropane Derivatives and Preparations Containing them |
US3674836A (en) | 1968-05-21 | 1972-07-04 | Parke Davis & Co | 2,2-dimethyl-{11 -aryloxy-alkanoic acids and salts and esters thereof |
US4058552A (en) | 1969-01-31 | 1977-11-15 | Orchimed Sa | Esters of p-carbonylphenoxy-isobutyric acids |
DE2003430C3 (de) | 1969-01-31 | 1978-12-07 | Laboratorien Fournier Gmbh, 6600 Saarbruecken | p-Benzoylphenoxyisobuttersäureester, ihre Herstellung und diese enthaltende Arzneimittel |
FI52570C (fi) | 1969-04-16 | 1977-10-10 | Sumitomo Chemical Co | Menetelmä veren kolesteroli- tai lipoidipitoisuutta alentavien fenoxia lifaattisten karboksyylihappoyhdisteiden ja -esteriyhdisteiden valmist amiseksi. |
GB1268082A (en) | 1969-08-08 | 1972-03-22 | Orsymonde | Improvements in or relating to bis-(carboxy-alkylene-thio)-decanes |
AT296986B (de) | 1969-08-13 | 1972-03-10 | Merz & Co | Verfahren zur Herstellung von neuen α-Halogenphenoxy-isobutyroyl-β-nicotinoyl-glykolen |
US3840504A (en) * | 1970-01-26 | 1974-10-08 | Hercules Inc | Reaction products of epihalohydrin and polymers of diallylamine and their use in paper |
US3700623A (en) * | 1970-04-22 | 1972-10-24 | Hercules Inc | Reaction products of epihalohydrin and polymers of diallylamine and their use in paper |
US3833531A (en) * | 1970-04-22 | 1974-09-03 | Hercules Inc | Reaction products of epihalohydrin and polymers of diallylamine and salts thereof and their use in paper |
DE2230383C3 (de) | 1971-10-01 | 1981-12-03 | Boehringer Mannheim Gmbh, 6800 Mannheim | Phenoxyalkylcarbonsäurederivate und Verfahren zur Herstellung derselben |
DE2149070C3 (de) | 1971-10-01 | 1978-03-23 | Boehringer Mannheim Gmbh, 6800 Mannheim | Phenoxyalkylcarbonsäurederivate und deren Salze, Verfahren zu deren Herstellung und Arzneimittel |
US3948973A (en) | 1972-08-29 | 1976-04-06 | Sterling Drug Inc. | Halocyclopropyl substituted phenoxyalkanoic acids |
AU472260B2 (en) * | 1972-12-22 | 1976-05-20 | Commonwealth Scientific + Industrial Research Organisation And Ici Australia Limited | A process OF POLYMERISATION OF ALLYL AMINES |
US3966694A (en) * | 1973-02-21 | 1976-06-29 | Hercules Incorporated | Cationic water soluble polymeric reaction product of poly(diallylamine)-epihalohydrin and nitrogen compound |
DE2308826C3 (de) | 1973-02-22 | 1980-03-27 | Ludwig Merckle Kg Chem. Pharm. Fabrik, 7902 Blaubeuren | Phenoxyalkancarbonsäureester von Oxyalkyltheophyllinen, Verfahren zu ihrer Herstellung und Arzneimittel |
US4027009A (en) * | 1973-06-11 | 1977-05-31 | Merck & Co., Inc. | Compositions and methods for depressing blood serum cholesterol |
FR2244511B1 (es) | 1973-07-05 | 1977-07-15 | Roussel Uclaf | |
CH617417A5 (es) | 1973-12-27 | 1980-05-30 | Siegfried Ag | |
JPS5612114B2 (es) | 1974-06-07 | 1981-03-18 | ||
JPS5157793A (ja) * | 1974-11-15 | 1976-05-20 | Nitto Boseki Co Ltd | Jiariruaminjudotaino jugotaio seizosuru hoho |
US4121986A (en) * | 1975-05-07 | 1978-10-24 | Ici Australia Limited | Process for the polymerization of polyallylamines in the presence of a mineral acid solution |
US4049813A (en) | 1976-07-15 | 1977-09-20 | Sandoz, Inc. | Substituted isoxazolo pyridinones |
AU509755B2 (en) | 1976-12-13 | 1980-05-22 | Commonwealth Scientific And Industrial Research Organisation | Basic ion exchange resins |
US4298715A (en) * | 1978-03-01 | 1981-11-03 | Monsanto Company | Polyamine/epihalohydrin reaction products |
AU535944B2 (en) | 1979-06-15 | 1984-04-12 | Merck & Co., Inc. | Hypocholestermic fermentation products from aspergillus |
US4231938A (en) | 1979-06-15 | 1980-11-04 | Merck & Co., Inc. | Hypocholesteremic fermentation products and process of preparation |
JPS5618611A (en) * | 1979-07-24 | 1981-02-21 | Nippon Kayaku Co Ltd | Production of diallyldialkylammonium chloride |
US4230626A (en) | 1979-07-30 | 1980-10-28 | G. D. Searle & Co. | 25-Halocholest-5-ene-3β,22-diols and esters thereof |
JPS5651992A (en) | 1979-10-03 | 1981-05-09 | Sankyo Co Ltd | Preparation of physiologically active substance ml-236b |
AU548996B2 (en) | 1980-02-04 | 1986-01-09 | Merck & Co., Inc. | Tetrahydro-2h-pyran-2-one derivatives |
US4444784A (en) | 1980-08-05 | 1984-04-24 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
DK149080C (da) | 1980-06-06 | 1986-07-28 | Sankyo Co | Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre |
US4450171A (en) | 1980-08-05 | 1984-05-22 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
IE52006B1 (en) * | 1980-12-12 | 1987-05-13 | Smith & Nephew Ass | Polymers of diallyl ammonium monomers pharmaceutical compositions thereof |
US4452957A (en) * | 1982-08-11 | 1984-06-05 | National Starch And Chemical Corporation | Process for the production of homo- and co-polymers of quaternary ammonium monomers |
US4739073A (en) | 1983-11-04 | 1988-04-19 | Sandoz Pharmaceuticals Corp. | Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof |
CH660852A5 (de) * | 1982-11-23 | 1987-05-29 | Aligena Ag | Dynamische membranen, die sich als duenne polymerschichten auf poroesen, polymeren traegermaterialien befinden. |
JPS6088018A (ja) * | 1983-10-21 | 1985-05-17 | Nitto Boseki Co Ltd | モノアリルアミンとジアリルアミン誘導体との共重合体の製造方法 |
US4604217A (en) * | 1984-09-13 | 1986-08-05 | Hercules Incorporated | Gelled aqueous compositions |
JPS6322056A (ja) | 1986-04-30 | 1988-01-29 | サンド・アクチエンゲゼルシヤフト | オレフイン性化合物の製造法 |
EP0245003A3 (en) | 1986-05-05 | 1989-07-19 | Merck & Co. Inc. | Antihypercholesterolemic compounds |
US4759923A (en) * | 1987-06-25 | 1988-07-26 | Hercules Incorporated | Process for lowering serum cholesterol using poly(diallylmethylamine) derivatives |
US4946963A (en) | 1987-11-13 | 1990-08-07 | The University Of North Carolina At Chapel Hill | Compounds for the control of hyperlipidemia using N-substituted isoxazolidine-3,5-diones |
HU202842B (en) | 1988-01-27 | 1991-04-29 | May & Baker Ltd | Process for producing new isoquinolinone derivatives and pharmaceutical compositions containing them |
US5055613A (en) | 1988-02-18 | 1991-10-08 | G. D. Searle & Co. | Metabolites of pentanedioic acid derivatives |
US4853437A (en) * | 1988-03-04 | 1989-08-01 | Hercules Incorporated | Water- and caustic-insoluble, inswellable, fibrous, particulate crosslinked polymer |
WO1990000897A1 (en) | 1988-07-27 | 1990-02-08 | University Of North Carolina At Chapel Hill | Method for the control of hyperlipidemia |
US5200482A (en) * | 1988-09-12 | 1993-04-06 | The Dow Chemical Company | Process for the production of high molecular weight copolymers of diallyl ammonium monomers and acrylamide monomers in solution |
JPH02237988A (ja) | 1988-11-18 | 1990-09-20 | Nissan Chem Ind Ltd | イソオキサゾロピリジン系メバロノラクトン類 |
GB8829835D0 (en) * | 1988-12-21 | 1989-02-15 | Smith Kline French Lab | Compounds |
FR2642065B1 (fr) | 1989-01-24 | 1991-05-24 | Lipha | Derives d'acides benzocycloalcenyl dihydroxy alcanoiques, procede de preparation et medicaments les contenant |
CA2007641A1 (en) | 1989-02-01 | 1990-08-01 | Donald S. Karanewsky | Combination of squalene synthetase inhibitor and other type of serum cholesterol reducing agent and method for lowering serum cholesterol using such combination |
CA2016467A1 (en) | 1989-06-05 | 1990-12-05 | Martin Eisman | Method for treating peripheral atherosclerotic disease employing an hmg coa reductase inhibitor and/or a squalene synthetase inhibitor |
US4937259A (en) | 1989-06-09 | 1990-06-26 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
FI94339C (fi) | 1989-07-21 | 1995-08-25 | Warner Lambert Co | Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi |
US5316765A (en) | 1989-09-07 | 1994-05-31 | Karl Folkers Foundation For Biomedical And Clinical Research | Use of coenzyme Q10 in combination with HMG-CoA reductase inhibitor therapies |
DE3929913A1 (de) | 1989-09-08 | 1991-04-04 | Hoechst Ag | 4-hydroxytetrahydropyran-2-one sowie die entsprechenden dihydroxycarbonsaeurederivate, salze und ester, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate sowie vorprodukte |
JPH0627137B2 (ja) | 1989-09-22 | 1994-04-13 | 第一工業製薬株式会社 | ジアリルアミン及びその誘導体の重合方法 |
US5128366A (en) | 1990-07-05 | 1992-07-07 | Shinogi & Co., Ltd. | Pyrrole derivatives |
IE914179A1 (en) | 1990-12-07 | 1992-06-17 | Ici Plc | Nitrogen derivatives |
US5134155A (en) | 1991-08-08 | 1992-07-28 | Ortho Pharmaceutical Corporation | Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole compounds and their use as HMG-coA reductase inhibitors |
DK0580078T3 (da) * | 1992-07-22 | 1998-05-25 | Hoechst Ag | Polyvinylamin-derivater med hydrofyle centrer,fremgangsmåde til deres fremstilling samt anvendelse af forbindelserne som lægemidler, bærere af aktive stoffer og næringsmiddelhjælpestof. |
EP0580079B1 (de) * | 1992-07-22 | 1996-12-11 | Hoechst Aktiengesellschaft | Vernetzte, stickstoffhaltige Vinylcopolymere, Verfahren zu ihrer Herstellung sowie die Verwendung dieser Verbindungen |
AU672824B2 (en) | 1992-08-20 | 1996-10-17 | E.I. Du Pont De Nemours And Company | Crosslinked polymeric ammonium salts |
US5556619A (en) | 1992-08-20 | 1996-09-17 | The Du Pont Merck Pharmaceutical Company | Crosslinked polymeric ammonium salts |
US5310949A (en) | 1992-09-02 | 1994-05-10 | Merck & Co., Inc. | Cholesterol lowering compounds |
US5274155A (en) | 1992-12-07 | 1993-12-28 | E. R. Squibb & Sons, Inc. | Intramolecular arbuzov process for the preparation of intermediates useful in the preparation of phosphorus containing HMG-COA reductase inhibitors |
US5618530A (en) * | 1994-06-10 | 1997-04-08 | Geltex Pharmaceuticals, Inc. | Hydrophobic amine polymer sequestrant and method of cholesterol depletion |
US5624963A (en) * | 1993-06-02 | 1997-04-29 | Geltex Pharmaceuticals, Inc. | Process for removing bile salts from a patient and compositions therefor |
US5703188A (en) * | 1993-06-02 | 1997-12-30 | Geltex Pharmaceuticals, Inc. | Process for removing bile salts from a patient and compositions therefor |
US5607669A (en) * | 1994-06-10 | 1997-03-04 | Geltex Pharmaceuticals, Inc. | Amine polymer sequestrant and method of cholesterol depletion |
JP3498853B2 (ja) | 1993-09-27 | 2004-02-23 | 小野薬品工業株式会社 | ビフェニル誘導体 |
ZA95390B (en) | 1994-01-18 | 1996-07-18 | Du Pont | Crosslinked polymeric ammonium salts |
US5414068A (en) * | 1994-01-24 | 1995-05-09 | Rohm And Haas Company | Crosslinked anion exchange particles and method for producing the particles |
TW474813B (en) | 1994-06-10 | 2002-02-01 | Geltex Pharma Inc | Alkylated composition for removing bile salts from a patient |
JP3006748B2 (ja) | 1994-09-06 | 2000-02-07 | 宇部興産株式会社 | 光学活性な7−置換ピリジル−3,5−ジヒドロキシ−ヘプト−6−エン酸エステル誘導体の製法 |
US5942297A (en) | 1996-03-07 | 1999-08-24 | Cryovac, Inc. | By-product absorbers for oxygen scavenging systems |
US6203785B1 (en) * | 1996-12-30 | 2001-03-20 | Geltex Pharmaceuticals, Inc. | Poly(diallylamine)-based bile acid sequestrants |
PL336415A1 (en) | 1997-03-11 | 2000-06-19 | Searle & Co | Combined therapy employing ileic bile acid transport inhibiting benzothiepins as well as a hmg co-enzyme reductase inhibitors |
GB2329334A (en) | 1997-09-18 | 1999-03-24 | Reckitt & Colmann Prod Ltd | Cholesterol-lowering agents |
US6083497A (en) * | 1997-11-05 | 2000-07-04 | Geltex Pharmaceuticals, Inc. | Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers |
US6726905B1 (en) * | 1997-11-05 | 2004-04-27 | Genzyme Corporation | Poly (diallylamines)-based phosphate binders |
-
1997
- 1997-11-05 US US08/964,536 patent/US6083497A/en not_active Expired - Lifetime
-
1998
- 1998-03-11 AR ARP980105512A patent/AR013742A1/es not_active Application Discontinuation
- 1998-10-23 ZA ZA989673A patent/ZA989673B/xx unknown
- 1998-10-26 ES ES98957370T patent/ES2196625T3/es not_active Expired - Lifetime
- 1998-10-26 AT AT98957370T patent/ATE235236T1/de active
- 1998-10-26 PL PL98340296A patent/PL340296A1/xx unknown
- 1998-10-26 KR KR1020007004892A patent/KR20010031822A/ko not_active Application Discontinuation
- 1998-10-26 IL IL13585898A patent/IL135858A0/xx unknown
- 1998-10-26 DE DE69812681T patent/DE69812681T2/de not_active Expired - Lifetime
- 1998-10-26 CA CA002309027A patent/CA2309027C/en not_active Expired - Lifetime
- 1998-10-26 HU HU0004279A patent/HUP0004279A3/hu unknown
- 1998-10-26 WO PCT/US1998/022605 patent/WO1999022721A2/en not_active Application Discontinuation
- 1998-10-26 CN CN98810752A patent/CN1278180A/zh active Pending
- 1998-10-26 JP JP2000518655A patent/JP4649039B2/ja not_active Expired - Lifetime
- 1998-10-26 NZ NZ504216A patent/NZ504216A/xx not_active IP Right Cessation
- 1998-10-26 BR BR9813961-4A patent/BR9813961A/pt not_active Application Discontinuation
- 1998-10-26 EP EP98957370A patent/EP1028717B1/en not_active Expired - Lifetime
- 1998-10-26 AU AU13646/99A patent/AU746876B2/en not_active Expired
- 1998-11-03 TW TW087118239A patent/TW453878B/zh not_active IP Right Cessation
-
1999
- 1999-05-13 US US09/311,103 patent/US6365186B1/en not_active Expired - Lifetime
- 1999-05-13 US US09/311,402 patent/US6264938B1/en not_active Expired - Lifetime
-
2000
- 2000-03-09 US US09/521,975 patent/US6248318B1/en not_active Expired - Lifetime
- 2000-04-27 NO NO20002172A patent/NO20002172L/no not_active Application Discontinuation
-
2001
- 2001-12-19 US US10/025,184 patent/US7638524B2/en not_active Expired - Fee Related
-
2009
- 2009-11-09 US US12/590,511 patent/US20100266526A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20100266526A1 (en) | 2010-10-21 |
ZA989673B (en) | 1999-05-11 |
NO20002172L (no) | 2000-07-04 |
EP1028717B1 (en) | 2003-03-26 |
ES2196625T3 (es) | 2003-12-16 |
US7638524B2 (en) | 2009-12-29 |
JP4649039B2 (ja) | 2011-03-09 |
BR9813961A (pt) | 2000-09-26 |
US6248318B1 (en) | 2001-06-19 |
JP2001521890A (ja) | 2001-11-13 |
US6365186B1 (en) | 2002-04-02 |
DE69812681D1 (de) | 2003-04-30 |
CA2309027C (en) | 2007-10-02 |
DE69812681T2 (de) | 2004-04-29 |
ATE235236T1 (de) | 2003-04-15 |
US20020155091A1 (en) | 2002-10-24 |
IL135858A0 (en) | 2001-05-20 |
HUP0004279A3 (en) | 2002-04-29 |
US6264938B1 (en) | 2001-07-24 |
TW453878B (en) | 2001-09-11 |
US6083497A (en) | 2000-07-04 |
NO20002172D0 (no) | 2000-04-27 |
NZ504216A (en) | 2002-11-26 |
WO1999022721A2 (en) | 1999-05-14 |
HUP0004279A2 (hu) | 2002-03-28 |
EP1028717A2 (en) | 2000-08-23 |
CN1278180A (zh) | 2000-12-27 |
CA2309027A1 (en) | 1999-05-14 |
AU746876B2 (en) | 2002-05-02 |
AU1364699A (en) | 1999-05-24 |
WO1999022721A3 (en) | 1999-08-05 |
KR20010031822A (ko) | 2001-04-16 |
PL340296A1 (en) | 2001-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR013742A1 (es) | Metodo para el tratamiento de la hipercolesterolemia con polidialilamina no substituida | |
MX9204268A (es) | Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma. | |
CO4950529A1 (es) | Dihidropirimidinas y productos que las contienen | |
MX9204625A (es) | Composicion farmaceutica para el tratamiento de una especie de mamifero, que sufre de deficiencia cardiaca congestiva. | |
KR950002785A (ko) | 골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜 | |
ES2168302T3 (es) | Tratamiento de trastornos y estados neuromusculares con toxina botulinica de serotipo e. | |
NO20053104D0 (no) | Oral, analgesisk doseringsform med forlenget frigivelse for administrering ±n gang pr. dag. | |
ES2128761T3 (es) | Formulacion de tirilazad con cosolvente para administracion parenteral. | |
DK0840606T3 (da) | Små di- og trivalente molekyler som selectininhibitorer | |
BR9503406A (pt) | Formulaçoes farmacêuticas adaptadas para inhibir para perda de osso em um ser humano | |
ITRM920412A1 (it) | Eteroprostanoidi, procedimento per la loro preparazione e loro impiego terapeutico. | |
DE59608698D1 (de) | Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden, enthaltend Sympthomimeticum und Pantothenol und/oder Pantothensäure | |
DK0998287T3 (da) | Anvendelse af levobupivacain | |
ES2193233T3 (es) | Uso de amiodipina, una sal de la misma o felodipina en combinacion con un inhibidor ace en la fabricacion de un medicamento para el tratamiento de insuficiencia cardiaca conjuntiva no isquemica. | |
ECSP930933A (es) | Composicion farmaceutica y procedimiento para prepararla | |
BR9509975A (pt) | Formulação farmacêutica | |
FR2716375B3 (fr) | Injecteur médical. | |
ES2089387T3 (es) | Tratamiento de la hipertension ocular con la ayuda de una combinacion sinergica. | |
FI962264A (fi) | Tulehduksia aiheuttavan sytokiinin muodostumisen inhibiittori, joka käsittää polyprenyylin johdannaisia aktiivisena ainesosana | |
MX9202595A (es) | Derivado de nucleosido. | |
CA2119777A1 (en) | An Ameliorant for Blood Lipid Metabolism | |
SE9404438D0 (sv) | New process | |
MX9204286A (es) | Agentes para el tratamiento de semillas. | |
AR005866A1 (es) | Composicion farmaceutica antioxidante | |
SE9602262D0 (sv) | New use of derivatives of cystine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |